Subscribe today to receive notice of our latest thought leadership, articles, and updates.
Insights
Recent updates
Sharing perspectives leads to greater understanding and fuels innovation

Check out our latest updates:
![]() |
July 18, 2023 · Clinical Team
The 2Q 2023 Brand-Generic Pipeline update Read more... |
![]() |
July 06, 2023 · Clinical Team
Extended-release Brixadi has been approved by the FDA for subcutaneous injection in patients recovering from Opioid Use Disorder as part of their treatment plan. Read more... |
Page 5 of 5